• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别实践差距,优化非酒精性脂肪性肝病患者的医疗护理。

Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.

机构信息

Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, 12631 E. 17th Avenue, MS B-158, Aurora, CO, 80045, USA,

出版信息

Dig Dis Sci. 2013 Oct;58(10):2809-16. doi: 10.1007/s10620-013-2740-8. Epub 2013 Jul 11.

DOI:10.1007/s10620-013-2740-8
PMID:23843097
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. Primary care providers (PCPs), in contrast to gastroenterology/hepatology (GI/Hep) providers, are the first medical contact for the majority of patients with, or at risk for, NAFLD. PCP awareness of and facility with NAFLD is critical for management of these patients.

AIM

The purpose of this study was to assess understanding and practice patterns of PCPs and non-GI/Hep subspecialty providers with respect to the diagnosis and management of NAFLD.

METHODS

We administered an online, 61-question survey to 479 providers in internal medicine, family medicine, endocrinology, cardiology, and obstetrics and gynecology (ObGyn) across three health systems: academic medical center, safety-net health system and managed care health system.

RESULTS

There were 246 respondents (51 %), with the majority (87 %) being PCPs (internal medicine, family medicine, ObGyn). Only 31 % of providers identified NAFLD as a clinically important diagnosis in their practice. Although 65 % of providers reported some degree of facility in diagnosing NAFLD, less than half (47 %) were comfortable managing NAFLD. Only 33 % refer patients with suspected NAFLD to GI/Hep. Subspecialists in endocrinology and cardiology reported greater clinical concern over NAFLD and were more likely (67 %) to refer patients with suspected NAFLD to GI/Hep.

CONCLUSIONS

The majority of providers do not identify NAFLD as a clinically important diagnosis and do not refer to GI/Hep. However, 83 % expressed a need for education on NAFLD. Our data reveal practice gaps within NAFLD care and identify opportunities for targeted education to guide PCPs in the evaluation and management of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是慢性肝病的主要原因。与胃肠病学/肝脏病学(GI/Hep)医生相比,初级保健医生(PCP)是大多数患有或有患 NAFLD 风险的患者的首要医疗联系人。PCP 对 NAFLD 的认识和处理能力对于这些患者的管理至关重要。

目的

本研究旨在评估 PCP 和非 GI/Hep 亚专科医生在诊断和管理 NAFLD 方面的理解和实践模式。

方法

我们向三个医疗系统(学术医疗中心、保障医疗系统和管理式医疗系统)的内科、家庭医学、内分泌学、心脏病学和妇产科(ObGyn)的 479 名医生进行了一项在线、61 个问题的调查。

结果

共有 246 名医生(51%)回复,其中大多数(87%)是 PCP(内科、家庭医学、ObGyn)。只有 31%的医生认为 NAFLD 是他们实践中的一个重要临床诊断。尽管 65%的医生表示在诊断 NAFLD 方面有一定程度的熟练程度,但只有不到一半(47%)的医生对管理 NAFLD 感到舒适。只有 33%的医生会将疑似 NAFLD 患者转介给 GI/Hep。内分泌学和心脏病学的专家表示对 NAFLD 的临床关注更多,并且更有可能(67%)将疑似 NAFLD 患者转介给 GI/Hep。

结论

大多数医生并不认为 NAFLD 是一个重要的临床诊断,也不会转介给 GI/Hep。然而,83%的医生表示需要关于 NAFLD 的教育。我们的数据揭示了 NAFLD 治疗中的实践差距,并确定了有针对性的教育机会,以指导 PCP 评估和管理 NAFLD。

相似文献

1
Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.识别实践差距,优化非酒精性脂肪性肝病患者的医疗护理。
Dig Dis Sci. 2013 Oct;58(10):2809-16. doi: 10.1007/s10620-013-2740-8. Epub 2013 Jul 11.
2
Primary care practitioners survey of non-alcoholic fatty liver disease.基层医疗从业者对非酒精性脂肪性肝病的调查。
Ann Hepatol. 2013 Sep-Oct;12(5):758-65.
3
Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.医院专家对非酒精性脂肪性肝病的认知和看法。
Intern Med J. 2013 Mar;43(3):247-53. doi: 10.1111/j.1445-5994.2012.02848.x.
4
Survey of physicians' knowledge about pediatric nonalcoholic fatty liver disease in China.中国儿科医师对非酒精性脂肪性肝病认知的调查。
J Dig Dis. 2024 Jun;25(6):380-393. doi: 10.1111/1751-2980.13297. Epub 2024 Jul 11.
5
Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.基层医疗医生和专科医生对非酒精性脂肪性肝炎的认知及相关实践模式
BMC Res Notes. 2016 Mar 11;9:157. doi: 10.1186/s13104-016-1946-1.
6
Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.了解初级保健医生对非酒精性脂肪性肝病诊断和管理的观点:一项定性研究。
Inquiry. 2024 Jan-Dec;61:469580241241272. doi: 10.1177/00469580241241272.
7
Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program.全科医生改善非酒精性脂肪性肝病管理:一项教育培训项目的批判性评估及影响
J Gastrointestin Liver Dis. 2008 Dec;17(4):389-94.
8
Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.初级保健提供者与非酒精性脂肪性肝病:一项需求评估调查。
Dig Dis Sci. 2023 Feb;68(2):434-438. doi: 10.1007/s10620-022-07706-2. Epub 2022 Sep 30.
9
Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.非酒精性脂肪性肝炎的诊断和治疗:从患者和初级保健医生的角度进行的横断面调查。
Ann Med. 2023 Dec;55(1):2211349. doi: 10.1080/07853890.2023.2211349.
10
Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.基层医疗医生对儿童非酒精性脂肪性肝病的认知、管理及实践模式
Paediatr Child Health. 2021 Aug 27;27(2):93-98. doi: 10.1093/pch/pxab057. eCollection 2022 May.

引用本文的文献

1
Barriers to care linkage and educational impact on unnecessary MASLD referrals.护理联系的障碍以及对不必要的代谢功能障碍相关脂肪性肝病(MASLD)转诊的教育影响。
Front Med (Lausanne). 2024 Jul 25;11:1407389. doi: 10.3389/fmed.2024.1407389. eCollection 2024.
2
Care for Vulnerable Populations with Chronic Liver Disease: A Safety-Net Perspective.从安全网角度看慢性肝病弱势群体的护理
Healthcare (Basel). 2023 Oct 13;11(20):2725. doi: 10.3390/healthcare11202725.
3
Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts.

本文引用的文献

1
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.
2
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.非酒精性脂肪性肝病的诊断与管理:美国胃肠病学会、美国肝病研究协会和美国胃肠病学院实践指南
Gastroenterology. 2012 Jun;142(7):1592-609. doi: 10.1053/j.gastro.2012.04.001. Epub 2012 May 15.
3
女性非酒精性脂肪性肝病——当前认知与新观点
JHEP Rep. 2023 Jun 29;5(10):100835. doi: 10.1016/j.jhepr.2023.100835. eCollection 2023 Oct.
4
Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care.不同医疗服务专业人员对非酒精性脂肪性肝病/非酒精性脂肪性肝炎的管理差异:优化多学科护理的机会
J Multidiscip Healthc. 2022 Jul 19;15:1533-1545. doi: 10.2147/JMDH.S367607. eCollection 2022.
5
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.非酒精性脂肪性肝病:一种新出现的现代心血管疾病风险因素。
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495. eCollection 2022 May.
6
Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.基层医疗医生对儿童非酒精性脂肪性肝病的认知、管理及实践模式
Paediatr Child Health. 2021 Aug 27;27(2):93-98. doi: 10.1093/pch/pxab057. eCollection 2022 May.
7
Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care.血糖控制不佳的糖尿病患者中非酒精性脂肪性肝病的诊断不足:糖尿病护理中的行动呼吁。
J Endocr Soc. 2021 Oct 6;5(12):bvab155. doi: 10.1210/jendso/bvab155. eCollection 2021 Dec 1.
8
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?糖尿病中的非酒精性脂肪性肝病:何时转诊至肝病专家?
World J Diabetes. 2021 Sep 15;12(9):1479-1493. doi: 10.4239/wjd.v12.i9.1479.
9
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States.美国非酒精性脂肪性肝病成人对肝脏疾病认知度低。
Hepatol Commun. 2021 Nov;5(11):1833-1847. doi: 10.1002/hep4.1765. Epub 2021 Jul 1.
10
Defining comprehensive models of care for NAFLD.定义非酒精性脂肪性肝病的综合护理模式。
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):717-729. doi: 10.1038/s41575-021-00477-7. Epub 2021 Jun 25.
Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.
医院专家对非酒精性脂肪性肝病的认知和看法。
Intern Med J. 2013 Mar;43(3):247-53. doi: 10.1111/j.1445-5994.2012.02848.x.
4
A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France.一项针对法国大量执业胃肠病学家中 NAFLD 实践模式和认知的调查。
J Hepatol. 2012 Aug;57(2):376-83. doi: 10.1016/j.jhep.2012.03.019. Epub 2012 Apr 17.
5
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.非酒精性脂肪性肝病相关肝细胞癌:一种新出现的威胁。
J Hepatol. 2012 Jun;56(6):1384-91. doi: 10.1016/j.jhep.2011.10.027. Epub 2012 Feb 9.
6
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.荟萃分析:吡格列酮可改善非酒精性脂肪性肝炎患者的肝脏组织学和纤维化。
Aliment Pharmacol Ther. 2012 Jan;35(1):66-75. doi: 10.1111/j.1365-2036.2011.04912.x. Epub 2011 Nov 4.
7
Upper limits of normal for alanine aminotransferase activity in the United States population.美国人群丙氨酸氨基转移酶活性的正常值上限。
Hepatology. 2012 Feb;55(2):447-54. doi: 10.1002/hep.24725.
8
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.美国非酒精性脂肪性肝炎患者进行肝移植的频率和结果。
Gastroenterology. 2011 Oct;141(4):1249-53. doi: 10.1053/j.gastro.2011.06.061. Epub 2011 Jul 2.
9
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价:成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.
10
Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis.荟萃分析:胰岛素增敏剂治疗非酒精性脂肪性肝炎。
Aliment Pharmacol Ther. 2010 Nov;32(10):1211-21. doi: 10.1111/j.1365-2036.2010.04467.x. Epub 2010 Sep 23.